<DOC>
	<DOCNO>NCT00005814</DOCNO>
	<brief_summary>RATIONALE : Monoclonal antibody , cetuximab , locate tumor cell either kill deliver tumor-killing substance without harm normal cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining chemotherapy monoclonal antibody therapy radiation therapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine cetuximab , cisplatin , radiation therapy treat patient advanced stage III stage IV head neck cancer .</brief_summary>
	<brief_title>Cetuximab , Cisplatin , Radiation Therapy Treating Patients With Advanced Stage III Stage IV Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate patient newly diagnose recurrent , advanced stage III IV squamous cell carcinoma head neck treat 6 infusion cetuximab loading/maintenance dos combination 2 infusion cisplatin concurrent standard/delayed accelerate hyperfractionated radiotherapy follow 4 week single agent cetuximab . II . Assess safety profile treatment regimen patient population . III . Evaluate time disease progression survival patient treat regimen . IV . Assess impact treatment regimen quality life patient . OUTLINE : Patients receive load dose cetuximab IV 120 minute week 1 follow 5 weekly maintenance dose 60 minute week 2-6 . Patients receive cisplatin IV 30 minute week 1 4 begin 1 hour completion cetuximab infusion . Radiotherapy administer daily week 1-4 twice daily week 5 6 . Following initial 6 week treatment , patient receive additional cetuximab IV 30 minute weekly week 7-10 . Quality life assess baseline , within 4 week completion treatment , 3-4 month . Patients follow 4-6 week , 12-16 week , every 3 month 2 year , every 4 month 1 year , every 6 month 2 year . PROJECTED ACCRUAL : A maximum 25 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose recurrent , advanced stage III IV squamous cell carcinoma larynx , hypopharynx , oropharynx , oral cavity , paranasal sinus/nasal cavity M0 No nasopharyngeal cancer Measurable evaluable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % ECOG 02 Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm3 Granulocyte count least 1,500/mm3 Hemoglobin least 9 g/dL Platelet count least 100,000/mm3 Hepatic : Alkaline phosphatase great 2.5 time upper limit normal ( ULN ) AST great 2.5 time ULN Bilirubin great 1.5 time ULN Renal : Creatinine great 1 time ULN Creatinine clearance least 60 mL/min Calcium great 11.5 mg/dL Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No malignancy within past 3 year except nonmelanoma skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy : No prior murine monoclonal antibody therapy No prior cetuximab No prior immunotherapy Chemotherapy : At least 3 year since prior chemotherapy No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy head neck region No concurrent radiotherapy Surgery : At least 60 day since prior surgery Diagnostic biopsy allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>